肿瘤药-话题@MedSci

#肿瘤药#

125篇内容 | 3265人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1537771, encodeId=5d54153e7716a, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=史上超全抗肿瘤药物副作用应对手册，千万别错过！, objectType=article, longId=732822, objectId=4466e3282200, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4466e3282200, replyNumber=0, likeNumber=105, createdTime=2022-07-21, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4466e3282200, moduleTitle=史上超全抗肿瘤药物副作用应对手册，千万别错过！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4466e3282200)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537770, encodeId=5420153e77012, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=别只关心新型抗肿瘤药物，传统化疗药物也该学学了！, objectType=article, longId=732262, objectId=00d1e32262ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00d1e32262ad, replyNumber=0, likeNumber=126, createdTime=2022-07-14, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00d1e32262ad, moduleTitle=别只关心新型抗肿瘤药物，传统化疗药物也该学学了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00d1e32262ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537769, encodeId=0059153e769f3, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=转氨酶蹦极原来是受到了抗肿瘤药物的“惊吓”, objectType=article, longId=729152, objectId=e187e2915289, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e187e2915289, replyNumber=0, likeNumber=104, createdTime=2022-06-13, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e187e2915289, moduleTitle=转氨酶蹦极原来是受到了抗肿瘤药物的“惊吓”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e187e2915289)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537768, encodeId=9af9153e768ca, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=常用抗肿瘤药分类和不良反应，超全总结！, objectType=article, longId=727462, objectId=ae49e27462f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae49e27462f8, replyNumber=0, likeNumber=129, createdTime=2022-05-22, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae49e27462f8, moduleTitle=常用抗肿瘤药分类和不良反应，超全总结！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae49e27462f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537767, encodeId=99ac153e76789, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=常见小分子靶向抗肿瘤药不良反应，该如何处理？, objectType=article, longId=727215, objectId=a440e27215a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a440e27215a6, replyNumber=0, likeNumber=108, createdTime=2022-05-19, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a440e27215a6, moduleTitle=常见小分子靶向抗肿瘤药不良反应，该如何处理？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a440e27215a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537766, encodeId=a434153e76674, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=【即将直播】肿瘤3天训练营|Day 3：新型抗肿瘤药物不容忽视的药物不良反应, objectType=article, longId=726804, objectId=48f6e26804f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48f6e26804f6, replyNumber=0, likeNumber=98, createdTime=2022-05-15, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48f6e26804f6, moduleTitle=【即将直播】肿瘤3天训练营|Day 3：新型抗肿瘤药物不容忽视的药物不良反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48f6e26804f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537765, encodeId=00ee153e76512, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=八张表格，带你弄清楚抗肿瘤药物的分类, objectType=article, longId=725536, objectId=920ce2553676, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=920ce2553676, replyNumber=0, likeNumber=139, createdTime=2022-04-28, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=920ce2553676, moduleTitle=八张表格，带你弄清楚抗肿瘤药物的分类, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=920ce2553676)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537764, encodeId=bb31153e764f9, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=北京市卫健委发文，抗肿瘤药物超说明书用药有了执行标准！, objectType=article, longId=301820, objectId=1d4f30182039, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d4f30182039, replyNumber=0, likeNumber=136, createdTime=2022-03-29, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d4f30182039, moduleTitle=北京市卫健委发文，抗肿瘤药物超说明书用药有了执行标准！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d4f30182039)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537763, encodeId=00c0153e7630c, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=蜂皇浆除了养颜，还可大大缓解抗肿瘤药物引起的肝损伤！, objectType=article, longId=301602, objectId=15e230160212, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15e230160212, replyNumber=0, likeNumber=93, createdTime=2022-03-26, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15e230160212, moduleTitle=蜂皇浆除了养颜，还可大大缓解抗肿瘤药物引起的肝损伤！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15e230160212)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537762, encodeId=e5b7153e762b5, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=国家卫健委发布《新型抗肿瘤药物临床应用指导原则(2021年版)》, objectType=article, longId=293189, objectId=c1e7293189ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1e7293189ce, replyNumber=0, likeNumber=101, createdTime=2022-01-01, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1e7293189ce, moduleTitle=国家卫健委发布《新型抗肿瘤药物临床应用指导原则(2021年版)》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1e7293189ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537761, encodeId=0a38153e761c3, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=指南推荐：生物标志物在抗肿瘤药物临床研发中应用的技术指导原则, objectType=article, longId=221772, objectId=456e221e72e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=456e221e72e8, replyNumber=0, likeNumber=76, createdTime=2021-12-11, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=456e221e72e8, moduleTitle=指南推荐：生物标志物在抗肿瘤药物临床研发中应用的技术指导原则, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=456e221e72e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537760, encodeId=2fd6153e76000, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=《生物标志物在抗肿瘤药物临床研发中应用的技术指导原则》发布, objectType=article, longId=221728, objectId=cf85221e28cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf85221e28cc, replyNumber=0, likeNumber=87, createdTime=2021-12-10, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf85221e28cc, moduleTitle=《生物标志物在抗肿瘤药物临床研发中应用的技术指导原则》发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf85221e28cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537759, encodeId=23bf153e75992, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=林根教授谈新冠肺炎疫情逐步控制下肺癌患者的诊疗建议，推荐合适的患者接受口服抗肿瘤药物治疗, objectType=article, longId=221294, objectId=313a221294fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=313a221294fd, replyNumber=0, likeNumber=118, createdTime=2021-12-01, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=313a221294fd, moduleTitle=林根教授谈新冠肺炎疫情逐步控制下肺癌患者的诊疗建议，推荐合适的患者接受口服抗肿瘤药物治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=313a221294fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537758, encodeId=1eba153e758e1, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=新型抗肿瘤药物：第三代紫杉醇在晚期非小细胞肺癌中的应用, objectType=article, longId=220746, objectId=731b220e4632, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=731b220e4632, replyNumber=0, likeNumber=71, createdTime=2021-11-23, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=731b220e4632, moduleTitle=新型抗肿瘤药物：第三代紫杉醇在晚期非小细胞肺癌中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=731b220e4632)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537757, encodeId=82a2153e757f4, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=《以临床价值为导向的抗肿瘤药物临床研发指导原则》正式稿发布, objectType=article, longId=220645, objectId=99bc22064555, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99bc22064555, replyNumber=0, likeNumber=89, createdTime=2021-11-21, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99bc22064555, moduleTitle=《以临床价值为导向的抗肿瘤药物临床研发指导原则》正式稿发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99bc22064555)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537756, encodeId=18a9153e75678, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=2021年上半年盘点：FDA批准抗肿瘤药物汇总, objectType=article, longId=213749, objectId=b40b213e49de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b40b213e49de, replyNumber=0, likeNumber=140, createdTime=2021-07-06, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b40b213e49de, moduleTitle=2021年上半年盘点：FDA批准抗肿瘤药物汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b40b213e49de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537755, encodeId=fa3d153e75537, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=国内埃博霉素类肿瘤药或诞生：乳腺癌1类新药“在审批”, objectType=article, longId=209543, objectId=0bbf20954327, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bbf20954327, replyNumber=0, likeNumber=107, createdTime=2021-04-05, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bbf20954327, moduleTitle=国内埃博霉素类肿瘤药或诞生：乳腺癌1类新药“在审批”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bbf20954327)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537754, encodeId=1d7e153e7549e, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=FDA联合用药方案中肿瘤药物的交叉标记（草案） 2020, objectType=article, longId=208537, objectId=953e20853ec5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=953e20853ec5, replyNumber=0, likeNumber=71, createdTime=2021-03-18, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=953e20853ec5, moduleTitle=FDA联合用药方案中肿瘤药物的交叉标记（草案） 2020, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=953e20853ec5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537753, encodeId=15fe153e7536d, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=全球肿瘤药巨头排名TOP10, objectType=article, longId=208102, objectId=f05220810249, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f05220810249, replyNumber=0, likeNumber=92, createdTime=2021-03-09, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f05220810249, moduleTitle=全球肿瘤药巨头排名TOP10, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f05220810249)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537752, encodeId=7169153e7528d, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=Science：抗肿瘤药物plitidepsin有望成为新型抗新冠病毒药物，比瑞德西韦强27倍, objectType=article, longId=206483, objectId=932c206483ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=932c206483ba, replyNumber=0, likeNumber=125, createdTime=2021-02-01, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=932c206483ba, moduleTitle=Science：抗肿瘤药物plitidepsin有望成为新型抗新冠病毒药物，比瑞德西韦强27倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=932c206483ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肿瘤药

2020-05-29

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

史上超全抗肿瘤药物副作用应对手册，千万别错过！

2022-07-21

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

别只关心新型抗肿瘤药物，传统化疗药物也该学学了！

2022-07-14

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

转氨酶蹦极原来是受到了抗肿瘤药物的“惊吓”

2022-06-13

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

常用抗肿瘤药分类和不良反应，超全总结！

2022-05-22

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

常见小分子靶向抗肿瘤药不良反应，该如何处理？

2022-05-19

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

【即将直播】肿瘤3天训练营|Day 3：新型抗肿瘤药物不容忽视的药物不良反应

2022-05-15

柳叶一刀 (审核中...)

前往app查看评论内容

#肿瘤药#

八张表格，带你弄清楚抗肿瘤药物的分类

2022-04-28

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

北京市卫健委发文，抗肿瘤药物超说明书用药有了执行标准！

2022-03-29

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

蜂皇浆除了养颜，还可大大缓解抗肿瘤药物引起的肝损伤！

2022-03-26

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

国家卫健委发布《新型抗肿瘤药物临床应用指导原则(2021年版)》

2022-01-01

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

指南推荐：生物标志物在抗肿瘤药物临床研发中应用的技术指导原则

2021-12-11

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

《生物标志物在抗肿瘤药物临床研发中应用的技术指导原则》发布

2021-12-10

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

林根教授谈新冠肺炎疫情逐步控制下肺癌患者的诊疗建议，推荐合适的患者接受口服抗肿瘤药物治疗

2021-12-01

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

新型抗肿瘤药物：第三代紫杉醇在晚期非小细胞肺癌中的应用

2021-11-23

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

《以临床价值为导向的抗肿瘤药物临床研发指导原则》正式稿发布

2021-11-21

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

2021年上半年盘点：FDA批准抗肿瘤药物汇总

2021-07-06

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

国内埃博霉素类肿瘤药或诞生：乳腺癌1类新药“在审批”

2021-04-05

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

FDA联合用药方案中肿瘤药物的交叉标记（草案） 2020

2021-03-18

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

全球肿瘤药巨头排名TOP10

2021-03-09

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

Science：抗肿瘤药物plitidepsin有望成为新型抗新冠病毒药物，比瑞德西韦强27倍

2021-02-01

科室
- - 订阅+
  - 更多科室
工具
服务